Page last updated: 2024-11-06

psicofuranine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID65086
CHEMBL ID453867
CHEBI ID8612
SCHEMBL ID691065
MeSH IDM0062496

Synonyms (38)

Synonym
adenine, 9beta-d-psicofuranosyl-
adenine, 9-beta-d-psicofuranosyl-
9-beta-d-psicofuranosyl-9h-purin-6-amine
9h-purin-6-amine, 9-beta-d-psicofuranosyl-
brn 0095142
ai3-50820
9h-purine, 6-amino-9-beta-d-psicofuranosyl-
9-beta-d-psicofuranosyladenine
u-9586
PDSP2_001021
PDSP1_001037
psicofuranine
C05342
angustmycin c
1874-54-0
(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-2,5-bis(hydroxymethyl)oxolane-3,4-diol
chebi:8612 ,
CHEMBL453867
unii-nn8z1mzb7l
4-26-00-03694 (beilstein handbook reference)
nn8z1mzb7l ,
1'-c-(hydroxymethyl)adenosine
psicofuranine [mi]
SCHEMBL691065
psicofuranin
HB4040
(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-2,5-bis(hydroxymethyl)tetrahydrofuran-3,4-diol
DTXSID80172052
J-012069
hydroxymethyladenosine
Q27108113
HY-119819
CS-0078071
MS-24262
bdbm50519499
BAA87454
(2r,3r,4s,5r)-2-(6-amino-9h-purin-9-yl)-2,5-bis(hydroxymethyl)oxolane-3,4-diol
AKOS040742517
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
purine nucleoside
psicose derivativeA deoxyketohexose derivative that is formally obtained from a psicose.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (4)

Processvia Protein(s)Taxonomy
GMP biosynthetic processGMP synthase [glutamine-hydrolyzing] Homo sapiens (human)
GMP biosynthetic processGMP synthase [glutamine-hydrolyzing] Homo sapiens (human)
glutamine metabolic processGMP synthase [glutamine-hydrolyzing] Homo sapiens (human)
purine nucleobase biosynthetic processGMP synthase [glutamine-hydrolyzing] Homo sapiens (human)
purine ribonucleoside monophosphate biosynthetic processGMP synthase [glutamine-hydrolyzing] Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
GMP synthase activityGMP synthase [glutamine-hydrolyzing] Homo sapiens (human)
GMP synthase (glutamine-hydrolyzing) activityGMP synthase [glutamine-hydrolyzing] Homo sapiens (human)
ATP bindingGMP synthase [glutamine-hydrolyzing] Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
cytosolGMP synthase [glutamine-hydrolyzing] Homo sapiens (human)
cytosolGMP synthase [glutamine-hydrolyzing] Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1578767Antimalarial activity against Plasmodium falciparum 3D7 assessed as reduction in parasite growth incubated for 48 hrs by Giemsa-staining counting based microscopic analysis2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1578765Inhibition of human GMP synthase2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues.
AID1578766Inhibition of Plasmodium falciparum N-terminal His-tagged GMP synthase expressed in Escherichia coli AT2465 assessed as reduction in NADH formation incubated at 0.5 mM for 20 mins by spectrophotometric analysis relative to control2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (80.00)18.7374
1990's3 (12.00)18.2507
2000's1 (4.00)29.6817
2010's1 (4.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.14 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]